Diagnostic Accuracy of Interleukin 27 for the Diagnosis of Pleural Tuberculosis

Majid Marjani1, Amir Reza Aghebatkheyri1, Neda Dalil Roofchayee1,2

  • 1Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Tanaffos
|April 24, 2026
PubMed
Abstract

Insights

Interleukin 27 (IL27) shows promise as a diagnostic biomarker for pleural tuberculosis (TB). Elevated IL27 levels in pleural fluid can help accurately identify TB pleurisy, improving early detection.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Pleural tuberculosis (TB) is a common extrapulmonary form of TB.
  • Diagnosing pleural TB is challenging due to limitations in microbiological tests.
  • Novel diagnostic techniques are needed for improved early detection and patient outcomes.

Purpose of the Study:

  • To investigate the diagnostic accuracy of interleukin 27 (IL27) for pleural tuberculosis.
  • To determine the sensitivity and specificity of IL27 as a biomarker for TB pleurisy.

Main Methods:

  • A study was conducted on 121 adult patients with unexplained pleural effusion.
  • Pleural fluid IL27 concentrations were measured using ELISA.
  • IL27 levels were compared between patients with and without TB pleurisy.

Main Results:

  • A cut-off threshold of 679 pg/ml for IL27 demonstrated 95% sensitivity and 69% specificity for diagnosing TB pleurisy.
  • The negative and positive predictive values were 94% and 73%, respectively (P<0.001).
  • Adenosine deaminase (ADA) levels did not significantly differ between TB and non-TB cases.

Conclusions:

  • Interleukin 27 levels were significantly higher in patients with TB pleurisy compared to other groups.
  • IL27 is a valuable diagnostic biomarker for identifying TB pleurisy.
  • This finding supports the potential of IL27 for early and accurate diagnosis of pleural tuberculosis.